Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
about
Lymphoblastic lymphoma in childhood and adolescence.Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
P2860
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Value of intravenous 6-mercapt ...... rial (58881) of the EORTC CLG.
@en
Value of intravenous 6-mercapt ...... f a randomized phase III trial
@nl
type
label
Value of intravenous 6-mercapt ...... rial (58881) of the EORTC CLG.
@en
Value of intravenous 6-mercapt ...... f a randomized phase III trial
@nl
prefLabel
Value of intravenous 6-mercapt ...... rial (58881) of the EORTC CLG.
@en
Value of intravenous 6-mercapt ...... f a randomized phase III trial
@nl
P2093
P2860
P356
P1433
P1476
Value of intravenous 6-mercapt ...... rial (58881) of the EORTC CLG.
@en
P2093
Bertrand Y
Mazingue F
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403689
P577
2005-05-01T00:00:00Z
P5875
P6179
1017859408